FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
0001365916FALSE00013659162022-08-092022-08-09 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWASHINGTON, D.C...
AMYRIS, INC. REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS PR Newswire EMERYVILLE, Calif., Aug. 9, 2022 Record consumer revenue of $43 million...
AMYRIS TO PARTICIPATE AT THE UBS GENOMICS 2.0 AND MEDTECH INNOVATIONS SUMMIT PR Newswire EMERYVILLE, Calif...
AMYRIS TO HOST SECOND QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON AUGUST 9 PR Newswire EMERYVILLE...
EATV, the World's First Plant-based Innovation ETF, Makes History at The New York Stock Exchange (NYSE:...
AMYRIS BARRA BONITA FERMENTATION PLANT BEGINS INDUSTRIAL PRODUCTION PR Newswire EMERYVILLE, Calif., June 23...
us03236m2008_060822.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...
us00773j1034_060822.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.